Ectopic ACTH Syndrome Caused by Multifocal Pulmonary Carsinoids with 18f-FDG Uptake: Case Report

2016 ◽  
Vol 11 (1) ◽  
pp. 22-26
Author(s):  
İlkay ÇAKIR ◽  
Tülay KAÇAR GÜVELİ ◽  
Zeynep TAŞDEMİR ◽  
Ramazan ALBAYRAK ◽  
Kamile KAYNAK ◽  
...  
2015 ◽  
Vol 62 (4) ◽  
pp. 202-204
Author(s):  
Irene Acevedo-Báñez ◽  
Juan Luis Tirado-Hospital ◽  
Ovidio Muñiz-Grijalvo ◽  
Miguel Angel Mangas-Cruz ◽  
Francisco Javier García-Gómez

2021 ◽  
Vol 0 (0) ◽  
pp. 0-0
Author(s):  
Jinxing Pan ◽  
Wei Lin ◽  
Liyao Zong ◽  
Junping Wen ◽  
Feng Jiang ◽  
...  

Author(s):  
Ziadoon Faisal ◽  
Miguel Debono

Summary In this case report, we describe the management of a patient who was admitted with an ectopic ACTH syndrome during the COVID pandemic with new-onset type 2 diabetes, neutrophilia and unexplained hypokalaemia. These three findings when combined should alert physicians to the potential presence of Cushing’s syndrome (CS). On admission, a quick diagnosis of CS was made based on clinical and biochemical features and the patient was treated urgently using high dose oral metyrapone thus allowing delays in surgery and rapidly improving the patient’s clinical condition. This resulted in the treatment of hyperglycaemia, hypokalaemia and hypertension reducing cardiovascular risk and likely risk for infection. Observing COVID-19 pandemic international guidelines to treat patients with CS has shown to be effective and offers endocrinologists an option to manage these patients adequately in difficult times. Learning points This case report highlights the importance of having a low threshold for suspicion and investigation for Cushing’s syndrome in a patient with neutrophilia and hypokalaemia, recently diagnosed with type 2 diabetes especially in someone with catabolic features of the disease irrespective of losing weight. It also supports the use of alternative methods of approaching the diagnosis and treatment of Cushing’s syndrome during a pandemic as indicated by international protocols designed specifically for managing this condition during Covid-19.


Author(s):  
Camila Edith Stachera Stasiak ◽  
David Henrique Nigri ◽  
Fabrícius Rocha Cardoso ◽  
Raphael Santos de Almeida Rezende d Mattos ◽  
Philippe Alcântara Gonçalves Martins ◽  
...  

This is a case report of a 37-year-old woman evaluated with 18F-fludeoxyglucose (18F-FDG) positron emission computed tomography/CT with recurrent fever after treatment with itraconazole for 6 weeks for histoplasmosis. The examination demonstrated a decrease in the dimensions of the pulmonary opacities previously identified in the left lower lobe and attributed to histoplasmosis. In addition to these pulmonary opacities, increased FDG uptake was also observed in lymph nodes present in the cervical region, mediastinum, left lung hilum, and hepatic hilum. Notably, other pulmonary opacities with ground-glass pattern that were not present in the previous computed tomography were detected in the right lower lobe, with mild 18F-FDG uptake. Nasal swab performed shortly after the examination was positive for COVID-19. In this case, the 18F-FDG positron emission computed tomography/CT study demonstrated findings consistent with active COVID-19 infection coexisting with inflammatory changes associated with histoplasmosis infection.


2015 ◽  
Vol 62 (4) ◽  
pp. 202-204
Author(s):  
Irene Acevedo-Báñez ◽  
Juan Luis Tirado-Hospital ◽  
Ovidio Muñiz-Grijalvo ◽  
Miguel Angel Mangas-Cruz ◽  
Francisco Javier García-Gómez

Sign in / Sign up

Export Citation Format

Share Document